Pediatric Testing
Periodontal Multiplex Detection Differentiation Porphyromonas Gingivalis Treponema Denticola Tannerella Forsythia Fusobacterium Nucleatum RNA Detection Qualitative Test
This test identifies specific bacteria linked to gum disease using advanced RNA detection technology. It helps guide targeted treatment for better oral health.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- Confirm with the laboratory before booking.
- Results
- Confirm with the laboratory before booking.
- Preparation
- Confirm with the laboratory before booking.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the Periodontal Multiplex Detection Differentiation Porphyromonas Gingivalis Treponema Denticola Tannerella Forsythia Fusobacterium Nucleatum RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Persistent bad breath
- ✓Swollen or bleeding gums
- ✓Loose teeth
- ✓Receding gums
- ✓Changes in bite
- ✓Risk factors like diabetes or smoking
- ✓Family history of periodontal disease
In plain language
What this test helps you understand
This test specifically measures the presence of RNA from the following bacteria: - Porphyromonas gingivalis - Treponema denticola - Tannerella forsythia - Fusobacterium nucleatum
These bacteria are commonly associated with periodontal disease and can lead to severe oral health complications if left untreated.
Individuals experiencing symptoms of gum disease such as persistent bad breath, swollen or bleeding gums, loose teeth, receding gums, or changes in bite should consider this test. Additionally, those with risk factors such as diabetes, smoking, or a family history of periodontal disease may benefit from this testing.
Benefits of taking this test include accurate identification of harmful bacteria for targeted treatment, early detection of periodontal diseases, guidance for dental professionals in creating personalized treatment plans, and improvement of overall oral health and hygiene.
Results will indicate the presence of the specific bacteria tested. A positive result for any of the bacteria may suggest an increased risk of periodontal disease. Discuss your results with a healthcare professional for further evaluation and management.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Newborn Screening Panel 2 Test
The Newborn Screening Panel 2 Test checks for Thyroid-Stimulating Hormone (TSH) and Glucose-6-Phosphate Dehydrogenase (G-6PD) levels in newborns to detect potential metabolic disorders early. Early detection allows for timely intervention and management.
Learn more →VANGL1 Gene Caudal Regression Syndrome Genetic Test
This genetic test identifies mutations in the VANGL1 gene associated with caudal regression syndrome using Next Generation Sequencing (NGS). It is recommended for individuals or families with a history of this condition or related dysmorphological features.
Learn more →